Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis-Reference-Cited by-同舟云学术

Prophylactic aprepitant is better than salvage for carboplatin-based chemotherapy: a propensity score-matched analysis

Published:2018-09-05 Issue:11 Volume:35 Page:
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Karayama Masato,Inui Naoki^ORCID,Tanaka Kazuki,Yasui Hideki,Hozumi Hironao,Suzuki Yuzo,Furuhashi Kazuki,Fujisawa Tomoyuki,Enomoto Noriyuki,Nakamura Yutaro,Suda Takafumi

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/article/10.1007/s12032-018-1199-z/fulltext.html

Reference37 articles.

1. Roscoe JA, Morrow GR, Hickok JT, Stern RM. Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices. J Pain Symptom Manag. 2000;20:113–21.

2. Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med. 2008;358:2482–94.

3. Griffin AM, Butow PN, Coates AS, Childs AM, Ellis PM, Dunn SM, et al. On the receiving end V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol. 1996;7:189–95.

4. Molassiotis A, Strick CT, Eaby B, Velders L, Coventy PA. Understanding the concept of chemotherapy-related nausea: the patient experience. Eur J Cancer Care. 2008;17:444–53.

5. de Boer-Dennert M, de Wit R, Schmitz PI, Djontono J, v Beurden V, Stoter G, et al. Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists. Br J Cancer. 1997;76:1055–61.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adherence to antiemetic guidelines in solid cancer patients receiving highly emetogenic chemotherapy in Korea;Supportive Care in Cancer;2024-02-24

2. Type: Original Article Adherence to antiemetic guidelines in solid cancer patients receiving highly emetogenic chemotherapy in Korea;2023-08-31

3. Study protocol for a prospective observational study to evaluate the efficacy of fosnetupitant for long-delayed chemotherapy-induced nausea and vomiting in patients receiving platinum- based chemotherapy (LODEC-N);2023-07-11

4. Adding aprepitant to palonosetron does not decrease carboplatin-induced nausea and vomiting in patients with gynecologic cancer;Journal of Pharmaceutical Health Care and Sciences;2021-06-01

5. Efficacy of one-day versus multiple-day dexamethasone for chemotherapy-induced nausea and vomiting in lung cancer patients receiving carboplatin-based chemotherapy: a propensity score–matched analysis;Supportive Care in Cancer;2021-02-16